
Maryam Monshipouri
Examiner (ID: 849)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1653, 1652, 1656, 1651 |
| Total Applications | 2170 |
| Issued Applications | 1561 |
| Pending Applications | 225 |
| Abandoned Applications | 434 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9857833
[patent_doc_number] => 20150037850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'RECOMBINANT MICROORGANISM PRODUCING QUINOLINIC ACID AND A METHOD FOR PRODUCING QUINOLINIC ACID USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/370721
[patent_app_country] => US
[patent_app_date] => 2013-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8325
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370721
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/370721 | Recombinant microorganism producing quinolinic acid and a method for producing quinolinic acid using the same | Jan 2, 2013 | Issued |
Array
(
[id] => 10070871
[patent_doc_number] => 09109218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Human arginase and pegylated human arginase and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/368507
[patent_app_country] => US
[patent_app_date] => 2012-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 10018
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/368507 | Human arginase and pegylated human arginase and the use thereof | Dec 22, 2012 | Issued |
Array
(
[id] => 9126598
[patent_doc_number] => 08574544
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-11-05
[patent_title] => 'Pharmaceutical composition of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/723775
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 36580
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13723775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/723775 | Pharmaceutical composition of nanoparticles | Dec 20, 2012 | Issued |
Array
(
[id] => 11657502
[patent_doc_number] => 09670494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Genetically engineered yeast cells'
[patent_app_type] => utility
[patent_app_number] => 14/370959
[patent_app_country] => US
[patent_app_date] => 2012-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6705
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370959
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/370959 | Genetically engineered yeast cells | Dec 16, 2012 | Issued |
Array
(
[id] => 9710580
[patent_doc_number] => 08835149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'DGAT genes comprising pleckstrin homology domains and methods of use for triglyceride production in recombinant microorganisms'
[patent_app_type] => utility
[patent_app_number] => 13/707287
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 36325
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707287
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707287 | DGAT genes comprising pleckstrin homology domains and methods of use for triglyceride production in recombinant microorganisms | Dec 5, 2012 | Issued |
Array
(
[id] => 9496537
[patent_doc_number] => 08735352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Adsorbent for blood coagulation factor or cell adhesion factor and method for purifying the factor'
[patent_app_type] => utility
[patent_app_number] => 13/705173
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7725
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13705173
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/705173 | Adsorbent for blood coagulation factor or cell adhesion factor and method for purifying the factor | Dec 4, 2012 | Issued |
Array
(
[id] => 8767154
[patent_doc_number] => 20130095191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'Passive Methods for Anti-Microbial Biologic Meshes'
[patent_app_type] => utility
[patent_app_number] => 13/692079
[patent_app_country] => US
[patent_app_date] => 2012-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5830
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692079
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/692079 | Passive methods for anti-microbial biologic meshes | Dec 2, 2012 | Issued |
Array
(
[id] => 9344454
[patent_doc_number] => 08663599
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-03-04
[patent_title] => 'Pharmaceutical composition of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/682929
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 26
[patent_no_of_words] => 28510
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682929
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682929 | Pharmaceutical composition of nanoparticles | Nov 20, 2012 | Issued |
Array
(
[id] => 11750587
[patent_doc_number] => 09708591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Polypeptides having endoglucanase activity and polynucleotides encoding same'
[patent_app_type] => utility
[patent_app_number] => 14/349833
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 41793
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349833
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349833 | Polypeptides having endoglucanase activity and polynucleotides encoding same | Nov 15, 2012 | Issued |
Array
(
[id] => 10615091
[patent_doc_number] => 09334526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Method for the production of human thrombin and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/355079
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6545
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355079
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/355079 | Method for the production of human thrombin and uses thereof | Oct 30, 2012 | Issued |
Array
(
[id] => 8875594
[patent_doc_number] => 08470558
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-06-25
[patent_title] => 'Use of mammalian expression vector including T7 promoter and N-terminal HA tag for overexpression of human genes in E. coli '
[patent_app_type] => utility
[patent_app_number] => 13/664465
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 8692
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13664465
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/664465 | Use of mammalian expression vector including T7 promoter and N-terminal HA tag for overexpression of human genes in E. coli | Oct 30, 2012 | Issued |
Array
(
[id] => 9523878
[patent_doc_number] => 08748140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Xylose-fermenting microorganism'
[patent_app_type] => utility
[patent_app_number] => 13/656613
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27760
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656613 | Xylose-fermenting microorganism | Oct 18, 2012 | Issued |
Array
(
[id] => 9656725
[patent_doc_number] => 20140227729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'N-DEMETHYASE GENES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/344037
[patent_app_country] => US
[patent_app_date] => 2012-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 29116
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344037 | N-demethyase genes and uses thereof | Oct 17, 2012 | Issued |
Array
(
[id] => 10939397
[patent_doc_number] => 20140342418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'XYLITOL PRODUCTION FROM CELLULOSIC BIOMASS'
[patent_app_type] => utility
[patent_app_number] => 14/350285
[patent_app_country] => US
[patent_app_date] => 2012-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18671
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350285
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350285 | XYLITOL PRODUCTION FROM CELLULOSIC BIOMASS | Oct 16, 2012 | Abandoned |
Array
(
[id] => 8759871
[patent_doc_number] => 08420390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Circular permutant GFP insertion folding reporters'
[patent_app_type] => utility
[patent_app_number] => 13/651211
[patent_app_country] => US
[patent_app_date] => 2012-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 38
[patent_no_of_words] => 20928
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651211
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/651211 | Circular permutant GFP insertion folding reporters | Oct 11, 2012 | Issued |
Array
(
[id] => 9720296
[patent_doc_number] => 20140255997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'GLUCOAMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/351469
[patent_app_country] => US
[patent_app_date] => 2012-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31606
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351469
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351469 | Glucoamylase variants and polynucleotides encoding same | Oct 10, 2012 | Issued |
Array
(
[id] => 9698570
[patent_doc_number] => 20140248255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'Novel Asparaginase and Treating Diseases Associated With Asparagine Dependence'
[patent_app_type] => utility
[patent_app_number] => 14/348637
[patent_app_country] => US
[patent_app_date] => 2012-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18970
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348637
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348637 | Asparaginase and treating diseases associated with asparagine dependence | Oct 8, 2012 | Issued |
Array
(
[id] => 9620733
[patent_doc_number] => 08790905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Fructosyl peptide oxidase'
[patent_app_type] => utility
[patent_app_number] => 13/633410
[patent_app_country] => US
[patent_app_date] => 2012-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18826
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633410
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/633410 | Fructosyl peptide oxidase | Oct 1, 2012 | Issued |
Array
(
[id] => 9671636
[patent_doc_number] => 20140235499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'ASSAY FOR INHIBITORS OF CIP/KIP PROTEIN DEGRADATION'
[patent_app_type] => utility
[patent_app_number] => 14/348141
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10143
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348141
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348141 | Assay for inhibitors of CIP/KIP protein degradation | Sep 27, 2012 | Issued |
Array
(
[id] => 10906128
[patent_doc_number] => 20140309141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'Methods of Screening for Inhibitors of Enzymes'
[patent_app_type] => utility
[patent_app_number] => 14/233537
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4682
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233537
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233537 | Methods of Screening for Inhibitors of Enzymes | Sep 20, 2012 | Abandoned |